As patient costs rise, so do middlemen profits. The 10 largest healthcare companies in the US don't treat a single patient. They're PBMs, insurers, and distributors taking in $2.6 trillion a year. The system was designed to work for them, not you.
Read:
https://t.co/BXdwDA3alH
A local East Grand Forks resident is sounding the alarm, #PBMs continue to keep affordable prescriptions out of reach for patients. Congress passed #PBMreform earlier this year, but follow-through matters and Minnesotans are watching.
Read more:
https://t.co/KkLRRPYtDR
A new report from the Minnesota Farmers Union finds that consolidation and anticompetitive practices by #PBMs limit opportunities for independent businesses and reduce consumer choice in the state. Lawmakers must act to protect local pharmacies.
Read More:
https://t.co/lpA60qISDy
New @econliberties report finds that prior authorization costs the US $32.7 billion yearly and 99,000 clinicians' worth of time. “For too long, prior authorization has allowed insurance companies to put profits ahead of patients...”
Read More:
https://t.co/vF99H8LnER
Minnesota recovered $495K from CVS after improper insulin billing cost the state over $857K...The fraud was possible because CVS owned both the pharmacy and the PBM auditing it. #PBMreforms should stop this vertical integration and demand more transparency https://t.co/yfa4q6A4Jt
Despite massively profiting from #340B programs, hospitals and care centers in MN are among the lowest spenders in charity care in the country, denying critical treatment for patients and aggressively pursuing medical debts. We need #340Breform : https://t.co/RyOCYrWSeK
New PBMA MN statement on #340B abuses in the state and the need for transparency as the Minnesota Legislature nears the end of the 2026 session. Read more here: @CLiverAlliance https://t.co/mHPnYyf6b7
MN hospitals and health systems are among the least charitable in the country, providing less financial aid as a % of their operating budgets on avg. than hospitals in almost every other state. Read more about the MN hopstial crisis & need for 340B reform: https://t.co/9BXhxbuPre
"...some pharmacies and #PBMs charge healthcare providers large fees for this #340B work, which can reduce the provider’s savings on those drug prices." said Dr. Sayeh Nikpay. 340B needs reforms. Read more here: https://t.co/qn8PwDHwRo
#340B hospitals get discounts not just on drugs prescribed to their low-income patients but to all their patients, even those of quite high incomes. “A lot of hospitals disproportionately put their contract pharmacies in places where people are wealthy": https://t.co/eo6vlfLzCA
#340B is an extremely profitable business opportunity for #PBM-owned and affiliated pharmacy networks. Unfortunately, Minnesota patients are the ones paying for it through inflated drug costs and increasing premiums. https://t.co/AIQJ6G0IfI
Originally intended as way to reach those in need, the #340B program has become a new source of revenue for #PBMs. According to this recent report, the Big 3 exploit the program through integrated contract pharmacies focused on profit, not patients.
https://t.co/qW1WD7iC4J
.@USCSchaeffer finds that just 3 #PBMs dominate MN Medicaid & Medicare Part D retail prescription markets, holding "outsized power over how much patients pay, where prescriptions are filled, and whether essential medications are covered.”
Read more here:
https://t.co/ZGMxN8PY7O
Express Scripts – owned by Cigna – is one of the nation's largest insurers. Learn more on how vertical integration of insuers and #PBMs impacts employer costs, pharmacy access, and what patients pay here: https://t.co/mEa3VbRpfc
Our mission is to ensure that Minnesotans can afford the prescription medicines they need and hold #PBMs accountable to the promises they’ve made. Learn more here: https://t.co/qSukF4x93g
"The biggest threat isn’t competition or changing health care - t’s pharmacy benefit managers, or PBMs." New op-ed in Missouri highlights the struggles pharmacists face accross the country due to #PBMs anticompetitive tactics. https://t.co/MOVTGnxD4z
.@USDOL annouced it will look at ways to improve transparency around the direct and indirect compensation #PBMs receive from employer-sponsored health plans. This is a promising sign from the Administration to increase #PBM reform efforts. https://t.co/DyL4QfCM06
New op-ed from the Pennsylvania State Grange highlights what is happening across the country: Rx drug costs are too high, and families, farmers, and small business owners are paying the price. We need widespread #PBM reform now. https://t.co/fRxKC1UVBA
The new @AmerMedicalAssn anaylsis titled: "Competition in PBM Markets and Vertical
Integration of Insurers with #PBMs", paints a clear picture of why transparency is crucial for drug insurance middlemen like #PBMs. Read the full report here: https://t.co/TMm05ke1co
We are encouraged to see bipartisan members of Congress introduce the #PBMReformAct which would bring much needed changes to the Rx drug system, providing relief for patients and independent pharmacies. https://t.co/qZXrPETRSp